Times are displayed in (UTC-05:00) Central Time (US & Canada) Change
5/4/2024 | 12:45 PM – 2:15 PM | Room W187
Block Symposium—T Cells in Cancer II
Moderators
Weiping Zou, Univ. of Michigan Med. Sch., USA
Brahm Segal, Roswell Park Comp. Cancer Ctr., USA
Tumor derived acidity enhances Treg suppressive functions against anti-tumor Teffs
Presentation Time: 12:45 PM–01:00 PM
Abstract ID: 5593 - B
Presenting Author:
Nikita L Mani, Northwestern Univ. Feinberg Sch. of Med.
Co-Authors:
Samuel E Weinberg, Northwestern Med.; Deyu Fang, Northwestern Univ. Feinberg Sch. of Med.;
View Abstract Details
SLAMF7+ CD8+ T cells exhibit decreased anti-tumor responses in renal cell carcinoma
Presentation Time: 01:00 PM–01:15 PM
Abstract ID: 5876 - B
Presenting Author:
Lena Wirth, Yale Univ.
Co-Authors:
Miya Hugaboom, Yale Sch. of Med.; Kelly Street, Keck Sch. of Med. of Univ. of Southern California; Neil Ruthen, Dana-Farber Cancer Inst.; Opeyemi Jegede, Dana-Farber Cancer Inst.; Nicholas Schindler, Yale Sch. of Med.; David McDermott, Beth Israel Deaconess Med. Ctr., Harvard Med. Sch.; Elizabeth Plimack, Fox Chase Cancer Ctr., Temple Hlth.; Jeffrey Sosman, Northwestern Univ.; Naomi Haas, Univ. of Pennsylvania; Michael Hurwitz, Yale Sch. of Med.; Hans Hammers, Univ. of Texas Southwestern Med. Ctr.; Sabina Signoretti, Brigham and Women's Hosp.; Michael Atkins, Lombardi Comp. Cancer Ctr., Georgetown Univ.; Catherine Wu, Dana-Farber Cancer Inst.; David Braun, Yale Sch. of Med.;
View Abstract Details
β-adrenergic signaling regulates erythropoiesis and through it; cancer immunity
Presentation Time: 01:15 PM–01:30 PM
Abstract ID: 5658 - B
Presenting Author:
Arshmeet K Chawla, UConn Hlth.
Co-Authors:
Adam T Hagymasi, UConn Hlth.; Rory J Geyer, UConn Hlth.; Ion I Mandoiu, UConn; Kenneth R Peterson, Univ. of Kansas Med. Ctr.; Vanessa M Scanlon, UConn Hlth.; Pramod K Srivastava, UConn Hlth.; James T Nevin, UConn Hlth.;
View Abstract Details
Targeting Pim2 improves effector function and longevity of T cells in cancer immunotherapy through regulating autophagy
Presentation Time: 01:30 PM–01:45 PM
Abstract ID: 5055 - B
Presenting Author:
Yongxia Wu, Med. Col. of Wisconsin
Co-Authors:
Linlu Tian, Med. Col. of Wisconsin; Allison Pugel, Med. Col. of Wisconsin; Xue-Zhong Yu, Med. Col. of Wisconsin;
View Abstract Details
Vasoactive intestinal peptide suppresses T cell activation via VPAC1 receptor and limits anti-tumor immunity.
Presentation Time: 01:45 PM–02:00 PM
Abstract ID: 5568 - B
Presenting Author:
Tenzin Passang, Winship Cancer Inst., Emory Univ.
Co-Authors:
Shuhua Wang, Winship Cancer Inst., Emory Univ.; Hanwen Zhang, Winship Cancer Inst., Emory Univ.; Jian-Ming Li, Winship Cancer Inst., Emory Univ.; Maggie Phillips, Winship Cancer Inst., Emory Univ.; Isaac Karpovsky, Winship Cancer Inst., Emory Univ.; Sruthi Ravindranathan, Winship Cancer Inst., Emory Univ.; Edmund K. Waller, Winship Cancer Inst., Emory Univ.;
View Abstract Details
CD8 T cells with an exhaustion-like phenotype remain highly functional in hematologic tumors
Presentation Time: 02:00 PM–02:15 PM
Abstract ID: 5980 - B
Presenting Author:
Simone A Minnie, Fred Hutchinson Cancer Res. Ctr.
Co-Authors:
Olivia G Waltner, Fred Hutchinson Cancer Res. Ctr.; Ping Zhang, Fred Hutchinson Cancer Res. Ctr.; Shuichiro Takahashi, Fred Hutchinson Cancer Res. Ctr.; Nicole S Nemychenkov, Fred Hutchinson Cancer Res. Ctr.; Kathleen S Ensbey, Fred Hutchinson Cancer Res. Ctr.; Samuel RW Legg, Fred Hutchinson Cancer Res. Ctr.; Melissa Comstock, Fred Hutchinson Cancer Res. Ctr.; Julie R Boiko, Fred Hutchinson Cancer Res. Ctr.; Shruti S Bhise, Fred Hutchinson Cancer Res. Ctr.; Alec B Wilkens, Fred Hutchinson Cancer Res. Ctr.; Motoko Koyama, Fred Hutchinson Cancer Res. Ctr.; Madhav V Dhodapkar, Emory Univ.; Marta Chesi, Mayo Clin., Arizona; Stanley R Riddell, Fred Hutchinson Cancer Res. Ctr.; Damian J Green, Fred Hutchinson Cancer Res. Ctr.; Andrew Spencer; Scott N Furlan, Fred Hutchinson Cancer Res. Ctr.; Geoffrey R Hill, Fred Hutchinson Cancer Res. Ctr.;
View Abstract Details